Modification of Platelet Count on the Association between Homocysteine and Blood Pressure: A Moderation Analysis in Chinese Hypertensive Patients
Table 2
The association between serum homocysteine and blood pressure according to platelet count.
Subgroups
z-transformed SBP
z-transformed DBP
β (SE)
for difference in β
β (SE)
for difference in β
Total participants
0.017 (0.013)
0.181
—
0.078 (0.012)
<0.001
—
Subgroup by quartiles of platelet count
Q1 (<146 × ×109/L)
−0.010 (0.025)
0.683
0.249
0.108 (0.024)
<0.001
0.003
Q2 (146–178 × 109/lL)
0.053 (0.026)
0.044
0.098 (0.025)
<0.001
Q3 (179–213 × 109/lL)
0.044 (0.026)
0.091
0.058 (0.025)
0.019
Q4 (≥214 × 109/L)
−0.027 (0.026)
0.297
0.039 (0.025)
0.119
Subgroup by platelet count referring to CSPPT
Platelet count <210 × 109/L
0.026 (0.015)
0.079
0.017
0.092 (0.014)
<0.001
0.004
Platelet count ≥210 × 109/L
−0.017 (0.025)
0.502
0.035 (0.024)
0.144
The increase of z-transformed SBP (β) per unit increment of log-transformed homocysteine and its significance test (); the increase of z-transformed DBP (β) per unit increment of log-transformed homocysteine and its significance test (); the significance test of the difference in the regression coefficients between the two subgroups.